Evidence map›Paper›PMID 23489396›Full record

Trial reportJournal of affective disorders2013

Changes in cognitive versus somatic symptoms of depression and event-free survival following acute myocardial infarction in the Enhancing Recovery In Coronary Heart Disease (ENRICHD) study.

Annelieke M Roest, Robert M Carney, Kenneth E Freedland, Elisabeth J Martens, Johan Denollet, Peter de Jonge

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of affective disorders, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Annelieke M RoestDepartment of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. a.m.roest@umcg.nl
Robert M Carney
Kenneth E Freedland
Elisabeth J Martens
Johan Denollet
Peter de Jonge
Tilburg University · NLWashington University in St. Louis · USUniversity Medical Center Groningen · NL

Funding

ENRICHD-N01HC55140-268055140N01HC055140 · HC · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · 1995 to 2005
$1.5M
ENRICHDN01HC055148 · HC · YALE UNIVERSITY · PI BURG, MATTHEW M. · 1995 to 2001
$358k
ENRICHDN01HC055144 · HC · RUSH UNIVERSITY MEDICAL CENTER · PI POWELL, LYNDA H · 1995 to 2001
$216k
ENRICHDN01HC055147 · HC · UNIVERSITY OF WASHINGTON · PI MITCHELL, PAMELA H. · 1995 to 2001
$204k
ENRICHDN01HC055142 · HC · DUKE UNIVERSITY · PI BLUMENTHAL, JAMES A. · 1995 to 2001
$178k
ENRICHDN01HC055145 · HC · STANFORD UNIVERSITY · PI DEBUSK, ROBERT FRANK · 1995 to 2001
$156k
ENRICHDN01HC055143 · HC · UNIVERSITY OF MIAMI CORAL GABLES · PI SCHNEIDERMAN, NEIL · 1995 to 2001
$148k
ENRICHDN01HC055146 · HC · WASHINGTON UNIVERSITY · PI CARNEY, ROBERT M · 1995 to 2001
$121k
ENRICHDN01HC055141 · HC · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI RACZYNSKI, JAMES M · 1995 to 2001
$112k
NHLBI NIH HHS N01 HC055140NHLBI NIH HHS N01 HC055141NHLBI NIH HHS N01 HC055142NHLBI NIH HHS N01 HC055143NHLBI NIH HHS N01 HC055144NHLBI NIH HHS N01 HC055145NHLBI NIH HHS N01 HC055146NHLBI NIH HHS N01 HC055147NHLBI NIH HHS N01 HC055148NHLBI NIH HHS N01-HC-55140NHLBI NIH HHS N01-HC-55141NHLBI NIH HHS N01-HC-55142NHLBI NIH HHS N01-HC-55143NHLBI NIH HHS N01-HC-55144NHLBI NIH HHS N01-HC-55145NHLBI NIH HHS N01-HC-55146NHLBI NIH HHS N01-HC-55147NHLBI NIH HHS N01-HC-55148
6 · The paper itself

Abstract

backgroundRandomized controlled trials focusing on the effects of antidepressant treatment in cardiac patients have found modest effects on depressive symptoms but not on cardiac outcomes. A secondary analysis was conducted on data from the Enhancing Recovery in Coronary Heart Disease trial to assess whether changes in somatic or cognitive depressive symptoms following acute MI predicted event-free survival and whether the results differed per treatment arm (cognitive behavior therapy or care as usual).

methodsPatients who met depression criteria and completed the 6th month depression assessment (n=1254) were included in this study. Measurements included demographic and clinical data and the Beck Depression Inventory at baseline and 6 months. The primary endpoint was a composite of recurrent MI and mortality over 2.4 years (standard deviation=0.9 years).

resultsPositive changes (per 1 point increase) in somatic depressive symptoms (HR: 0.95; 95% CI: 0.92-0.98; p=0.001) but not in cognitive depressive symptoms (HR: 0.98; 95% CI: 0.96-1.01; p=0.19) were related to a reduced risk of recurrent MI and mortality after adjustment for baseline depression scores. There was a trend for an interaction effect between changes in somatic depressive symptoms and the intervention (p=0.08). After controlling for demographic and clinical variables, the association between changes in somatic depressive symptoms and event-free survival remained significant in the intervention arm (HR: 0.93; 95% CI: 0.88-0.98; p=0.01) only. LIMITATIONS: Secondary analyses.

conclusionsChanges in somatic depressive symptoms, and not cognitive symptoms, were related to improved outcomes in the intervention arm, independent of demographic and clinical variables.

Indexed as

Cognitive Behavioral TherapyAgedAntidepressive AgentsCoronary DiseaseDepressive DisorderDisease-Free SurvivalFemaleHumansMaleMiddle AgedMyocardial InfarctionAntidepressive Agents

Identifiers

PMID23489396
PMCPMC3672326
OpenAlexW2098326472

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.